Antiviral activity against HIV-1 3B infected in human CEM cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by microscopic analysis
Antiviral activity against HIV-2 ROD infected in human CEM cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by microscopic analysis
Antiviral activity against HIV-1 3B infected in human MT4 cells assessed as inhibition of virus-induced cytopathicity after 7 days by trypan blue staining
Antiviral activity against HIV-2 ROD infected in human MT4 cells assessed as inhibition of virus-induced cytopathicity after 7 days by trypan blue staining
Antiviral activity against SIV mac251 infected in human MT4 cells assessed as inhibition of virus-induced cytopathicity after 7 days by trypan blue staining
Antiviral activity against HIV-1 3B infected in human C8166 cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by microscopic analysis
Antiviral activity against HIV-1 3B cells infected in human PBMC cells assessed as inhibition of virus-induced cytopathicity after 3 to 4 days by microscopic analysis
Antiviral activity against R5 tropic HIV-1 clade A isolate UG273 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against R5 tropic HIV-1 clade B isolate US2 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against R5 tropic HIV-1 clade C isolate ETH2220 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against X4 tropic HIV-1 clade D isolate UG270 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against R5 tropic HIV-1 clade A/E isolate ID12 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against R5 tropic HIV-1 clade F isolate BZ163 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against R5 tropic HIV-1 clade G isolate BCF-DIOUM infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA
Antiviral activity against X4 tropic HIV-1 group O isolate BCF06 infected in human PBMC assessed as inhibition of viral replication after 3 days by ELISA